Broach Lifecare Hospital Ltd vs Gujarat Kidney Super Speciality Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Broach Lifecare Hospital Ltd is ₹ 14 as of 05 Oct 15:30 . The P/E Ratio of Broach Lifecare Hospital Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Broach Lifecare Hospital Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 798.29 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Broach Lifecare Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 34.98 crore as compare to the Mar '26 revenue of ₹ 31.29 crore. This represent the growth of 11.79% The ebitda of Broach Lifecare Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 9.07 crore as compare to the Mar '26 ebitda of ₹ 7.01 crore. This represent the growth of 29.39% The net profit of Broach Lifecare Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 5.32 crore over 8 quarters. This represents a CAGR of 34.06% The Dividend Payout of Broach Lifecare Hospital Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 years .

About Broach Lifecare Hospital Ltd

Broach Lifecare Hospital Limited was incorporated as 'Broach Lifecare Hospital Private Limited' dated April 25, 2023, with the Registrar of Companies, Central Registration Centre.
Further, in accordance with the main objects, the Company acquired the sole proprietorship concerns of Dr. Jaykumar Narendra Vyas, the Promoter comprising of the Hospitals i.e.
Dr. Vyas's Heart Hospital and Dr. Vyas Hospital pursuant to a Business Transfer Agreement date July 17, 2023.
Thereafter, the Company was converted into a public limited Company and the name was changed to Broach Lifecare Hospital Limited' dated November 7, 2023 at ROC, Ahmedabad. The Company operates boutique Hospitals under the brand 'Maple Hospitals' and provides dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography in June 2023, the Company ventured into interventional cardiac services such as, coronary angiography and stenting, percutaneous coronary intervention (PCI) and primary PCI for acute myocardial infarction as a division.

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad. The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.

FAQs for the comparison of Broach Lifecare Hospital Ltd and Gujarat Kidney & Super Speciality Ltd

Which company has a larger market capitalization, Broach Lifecare Hospital Ltd or Gujarat Kidney & Super Speciality Ltd?

Market cap of Broach Lifecare Hospital Ltd is 8 Cr while Market cap of Gujarat Kidney & Super Speciality Ltd is 1,395 Cr

What are the key factors driving the stock performance of Broach Lifecare Hospital Ltd and Gujarat Kidney & Super Speciality Ltd?

The stock performance of Broach Lifecare Hospital Ltd and Gujarat Kidney & Super Speciality Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Broach Lifecare Hospital Ltd and Gujarat Kidney & Super Speciality Ltd?

As of October 25, 2026, the Broach Lifecare Hospital Ltd stock price is INR ₹14.0. On the other hand, Gujarat Kidney & Super Speciality Ltd stock price is INR ₹176.95.

How do dividend payouts of Broach Lifecare Hospital Ltd and Gujarat Kidney & Super Speciality Ltd compare?

To compare the dividend payouts of Broach Lifecare Hospital Ltd and Gujarat Kidney & Super Speciality Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.